Thyrocare Technologies Limited

HSBC Mutual Fund increased its stake in Thyrocare Technologies from 4.75% to 6.63%, buying 29,99,731 shares for ₹187.18 Cr at ₹624.00 apiece, crossing the 5% disclosure threshold.

A healthcare diagnostics provider, Thyrocare Technologies operates a network of diagnostic centers across India delivering laboratory testing and pathology services. The company partners with hospitals, clinics, and independent laboratories to offer affordable diagnostic solutions to patients nationwide. Its distinctive approach combines technology-enabled operations with cost-effective service delivery, making quality diagnostic care accessible across urban and semi-urban markets in India.

Indian arm of HSBC Asset Management, the investment arm of HSBC Group with over USD 600 billion in global AUM. Manages over Rs 1 lakh crore in India across equity, debt and hybrid schemes. Previously known for integration of L&T Mutual Fund schemes after acquiring it from L&T Finance in 2022, which significantly expanded the franchise.